Sun Pharmaceutical Industries Ltd has entered into an agreement with two large shareholders of its subsidiary Caraco Pharmaceutical Laboratories Ltd to acquire most of their common stock and......
Sun Pharmaceuticals and the foreign shareholders of the United States-based Caraco Pharmaceutical Laboratories, in which Sun has a 48 per cent stake, are at loggerheads over their shareholders'......
Sun Pharmaceuticals' US-based associate, Caraco Pharmaceutical Laboratories, has received the approval from the US Food and Drug Administration to manufacture and market yet another generic drug,......
Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS,......
Sun Pharma is voluntarily recalling 5,322 bottles of Ketorolac Tromethamine ophthalmic solution in the US market for failing to meet specifications. As per the information available on the USFDA......